Back to results
US 2021/0171439 A1Published application
Hepatitis b capsid assembly modulators
AssigneeVenatorx Pharmaceuticals, Inc.
InventorsChristopher J. BURNS, Glen COBURN, Bin LIU, Jiangchao YAO, Christopher BENETATOS, Steven A. Boyd, Stephen M. CONDON
Life of this patent
Estimating the term…
Abstract
Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.
Claims81
A compound of Formula (II), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof:
- wherein:
- Ring A is aryl, heteroaryl, cycloalkyl, or heterocycloalkyl;
- Ring B is
- or C2-5heteroaryl;
- R1 is —F, —Cl, —OH, or —OR;
- R2 is hydrogen, —F, —Cl, —CN, —ORa, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6heteroalkyl, or C3-8cycloalkyl;
- R3 is hydrogen or C1-6alkyl;
- each R4 is independently halogen, —CN, —OH, —ORa, —SH, —SRa, —S(═O)Ra, —NO2, —NRbRc, —S(═O)2Ra, —NHS(═O)2Ra, —S(═O)2NRbRc, —C(═O)Ra, —OC(═O)Ra, —C(═O)ORa, —OC(═O)ORb, —C(═O)NRbRc, —OC(═O)NRbRc, —NRbC(═O)NRbRc, —NRbC(═O)Ra, —NRbC(═O)ORb, C1-6alkyl, C1-6haloalkyl, C2-6alkenyl, C2-6alkynyl, C3-8cycloalkyl, C2-7heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one, two, or three R12;
- or two R4 on adjacent atoms are taken together with the atoms to which they are attached to form a carbocycle ring or a heterocycle ring;
- each optionally substituted with one, two, or three R12;
- each R5 is independently hydrogen, halogen, —CN, —OH, —ORa, —SH, —SRa, —S(═O)Ra, —NO2, —NRbRc, —S(═O)2Ra, —NHS(═O)2Ra, —S(═O)2NRbRc, —C(═O)Ra, —OC(═O)Ra, —C(═O)ORb, —OC(═O)ORb, —C(═O)NRbRc, —OC(═O)NRbRc, —NRbC(═O)NRbRc, —NRbC(═O)Ra, —NRbC(═O)ORb, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C2-6alkenyl, C2-6alkynyl, C3-8cycloalkyl, C2-7heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one, two, or three R13;
- or two Ron adjacent atoms are taken together with the atoms to which they are attached to form a carbocycle ring or a heterocycle ring;
- each optionally substituted with one, two, or three R13;
- R6 and R7 are each independently hydrogen, C1-6alkyl, C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-15cycloalkyl, C2-15heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- wherein each alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one, two, or three R10;
- or R6 and R7 are taken together with the nitrogen atom to which they are attached to form a C2-15heterocycloalkyl or a C2-15heterocycloalkenyl;
- wherein each heterocycloalkyl and heterocycloalkenyl is independently optionally substituted with one, two, or three R11;
- m is an integer from 0 to 5;
- n is an integer from 0 to 4;
- each R10 is independently oxo, halogen, —CN, —OH, —ORa, —SH, —SRa, —S(═O)Ra, —NO2, —NRbRc, —S(═O)2Ra, —NHS(═O)2Ra, —S(═O)2NRbRc, —C(═O)Ra, —OC(═O)Ra, —C(═O)ORa, —OC(═O)ORb, —C(═O)NRbRc, —OC(═O)NRbRc, —NRbC(═O)NRbRc, —NRbC(═O)Ra, —NRbC(═O)ORb, —B(ORd)2, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6heteroalkyl, C2-6alkenyl, C2-6alkynyl, C3-8cycloalkyl, C2-7heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- each R11 is independently oxo, halogen, —CN, —OH, —ORa, —SH, —SRa, —S(═O)Ra, —NO2, —NRbRc, —S(═O)2Ra, —NHS(═O)2Ra, —S(═O)2NRbRc, —NRS(═O)2NRbRc, —C(═O)Ra, —OC(═O)Ra, —C(═O)ORb, —OC(═O)ORb, —C(═O)NRbRc, —CH2C(═O)NRbRc, —OC(═O)NRbRc, —NRbC(═O)NRbRc, —NRbC(═O)Ra, —NRbC(═O)ORb, —NRbC(═O)CH2NRbRc, —C(═O)CH2NRbC(═O)NRbRc, —OP(═O)(ORb)(OR), —B(ORd)2, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6heteroalkyl, C1-6cyanoalkyl, C2-6alkenyl, C2-6alkynyl, C3-8cycloalkyl, C2-7heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- each R12 and R13 is independently halogen, —CN, —OH, —ORa, —SH, —SRa, —S(═O)Ra, —NO2, —NRbRc, —S(═O)2Ra, —NHS(═O)2Ra, —S(═O)2NRbRc, —C(═O)Ra, —OC(═O)Ra, —C(═O)ORa, —OC(═O)ORb, —C(═O)NRbRc, —OC(═O)NRbRc, —NRbC(═O)NRbRc, —NRbC(═O)Ra, —NRbC(═O)ORb, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6heteroalkyl, or C3-8cycloalkyl;
- each Ra is independently C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6heteroalkyl, C3-8cycloalkyl, C2-7heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one, two, or three oxo, halogen, —OH, C1-6alkyl, or C1-6haloalkyl;
- each Rb and Rc is independently hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6heteroalkyl, C3-8cycloalkyl, C2-7heterocycloalkyl, aryl, heteroaryl, C1-6alkyl(aryl), C1-6alkyl(heteroaryl), C1-6alkyl(C3-8cycloalkyl), or C1-6alkyl(C2-7heterocycloalkyl);
- wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one, two, or three oxo, halogen, —OH, C1-6alkyl, or C1-6haloalkyl;
- or Rb and Rc are taken together with the nitrogen atom to which they are attached to form a C2-7heterocycloalkyl optionally substituted with one, two, or three oxo, halogen, —OH, C1-6alkyl, or C1-6haloalkyl;
- and
- each R is independently hydrogen or C1-6alkyl;
- or two Rd are taken together to form a C2-7heterocycloalkyl optionally substituted with one, two, or three halogen, —OH, or C1-6alkyl.
29 more elements
A compound, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, selected from the group consisting of:
Dependencies are inferred from the claim text.